Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Juvenile arthritis

Pathophysiology

03-08-2018 | Pathophysiology | Review | Article

S100 proteins in rheumatic diseases

Austermann J, Spiekermann C, Roth J. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0058-9

08-06-2018 | Pain | Review | Article

Cannabinoids for the treatment of rheumatic diseases: Where do we stand?

Katz-Talmor D et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0025-5

16-05-2018 | Juvenile idiopathic arthritis | Review | Article

Vitamin D and juvenile idiopathic arthritis

In this review, Finch et al summarize and evaluate the current literature relating to vitamin D and juvenile idiopathic arthritis.

Finch SL, Rosenberg AM, Vatanparast H. Pediatr Rheumatol 2018; 16: 34. doi: 10.1186/s12969-018-0250-0

21-03-2018 | Pathogenesis | Review | Article

Type I interferon in rheumatic diseases

Wampler TL, Niewold TB. Nat Rev Rheumatol 2018; 14: 214–228. doi: 10.1038/nrrheum.2018.31

Read more

Epidemiology

07-04-2018 | Juvenile idiopathic arthritis | Article

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

05-06-2018 | Juvenile idiopathic arthritis | Article

A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

Unal E et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4075-4

16-05-2018 | Juvenile idiopathic arthritis | Review | Article

Vitamin D and juvenile idiopathic arthritis

In this review, Finch et al summarize and evaluate the current literature relating to vitamin D and juvenile idiopathic arthritis.

Finch SL, Rosenberg AM, Vatanparast H. Pediatr Rheumatol 2018; 16: 34. doi: 10.1186/s12969-018-0250-0

24-01-2018 | Pathogenesis | Review | Article

Moving towards a molecular taxonomy of autoimmune rheumatic diseases

Barturen G et al. Nat Rev Rheumatol 2018; 14: 75–93. doi: 10.1038/nrrheum.2017.220

Read more

Diagnosis and screening

28-09-2018 | Juvenile idiopathic arthritis | Article

Juvenile arthritis management in less resourced countries (JAMLess): Consensus recommendations from the cradle of humankind

Scott C et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4304-y

07-04-2018 | Juvenile idiopathic arthritis | Article

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

17-09-2018 | Juvenile idiopathic arthritis | Article

Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis

Ventura-Ríos L et al. Pediatr Rheumatol 2018; 16: 58. doi: 10.1186/s12969-018-0275-4

28-06-2018 | Juvenile idiopathic arthritis | Article

Association of hand grip strength with disease activity, disability, and quality of life in children and adolescents with juvenile idiopathic arthritis

Rashed AM et al. Adv Rheumatol 2018; 58: 11. doi: 10.1186/s42358-018-0012-1

Read more

Treatment

01-10-2018 | Juvenile idiopathic arthritis | Review | Article

Glucocorticoid treatment in juvenile idiopathic arthritis

Batu ED. Rheumatol Int 2018. doi: 10.1007/s00296-018-4168-0

28-09-2018 | Juvenile idiopathic arthritis | Article

Juvenile arthritis management in less resourced countries (JAMLess): Consensus recommendations from the cradle of humankind

Scott C et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4304-y

21-08-2018 | Juvenile idiopathic arthritis | Article

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Kearsley-Fleet L et al. Rheumatology (Oxford) 2018: key262. doi: 10.1093/rheumatology/key262

04-08-2018 | Biologics | Review | Article

A targeted literature review examining biologic therapy compliance and persistence in chronic inflammatory diseases to identify the associated unmet needs, driving factors, and consequences

Maniadakis N et al. Adv Ther 2018; 9: 1333–1355. doi: 10.1007/s12325-018-0759-0

Read more
Image Credits